Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Andrea Vergara-Silva
Evaluation of Classical Clinical Endpoints as Surrogates for Overall Survival in Patients Treated With Immune Checkpoint Blockers: A Systematic Review and Meta-Analysis
Journal of Cancer Research and Clinical Oncology
Medicine
Cancer Research
Oncology
Related publications
Risk of Hepatotoxicity in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis of Published Data
International Journal of Cancer
Cancer Research
Oncology
Nonselective Β-Blockers and Survival in Patients With Cirrhosis and Ascites: A Systematic Review and Meta-Analysis
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
Immune Checkpoint Inhibitor‐induced Type 1 Diabetes: A Systematic Review and Meta‐analysis
Diabetic Medicine
Internal Medicine
Endocrinology
Metabolism
Diabetes
Response Rate as a Potential Surrogate for Survival and Efficacy in Patients Treated With Novel Immune Checkpoint Inhibitors: A Meta-Regression of Randomised Prospective Studies
European Journal of Cancer
Cancer Research
Oncology
Risk of Pneumonitis and Pneumonia Associated With Immune Checkpoint Inhibitors for Solid Tumors: A Systematic Review and Meta-Analysis
Frontiers in Immunology
Allergy
Immunology
Survival Benefits of Metformin for Colorectal Cancer Patients With Diabetes: A Systematic Review and Meta-Analysis
PLoS ONE
Multidisciplinary
Clinical Significance of MicroRNAs in Patients With Sepsis: Protocol for a Systematic Review and Meta-Analysis
Diagnostics
Clinical Biochemistry
Impact of Clinicopathological Characteristics on Survival in Patients Treated With Immune Checkpoint Inhibitors for Metastatic Melanoma
International Journal of Cancer
Cancer Research
Oncology
Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-Analysis
Gastroenterology
Hepatology
Gastroenterology
